Integrated cardiac, endocrine, and genetic assessment in adolescent basketball players - Summary - MDSpire

Comprehensive Evaluation of Cardiac, Endocrine, and Genetic Factors in Young Basketball Athletes

  • By

  • Katerina Gregorova

  • Lukas Plachy

  • Vaclav Chaloupecky

  • Olena Iurchenko

  • Klara Maliska Maratova

  • Aneta Kodytkova

  • Martin Matoulek

  • Jan Lebl

  • Viktor Tomek

  • Zdenek Sumnik

  • Petra Dusatkova

  • Stepanka Pruhova

  • July 20, 2026

Share

Objective:

To investigate the phenotypic, endocrine, cardiac, and genetic characteristics of adolescent basketball players to identify possible causes of tall stature and associated health risks.

Approach:
  • Participants: 55 youth basketball players (30 females, median age 17 years and height +2.4 standard deviations) were examined.
  • Methods: Participants underwent detailed endocrine and anthropometric examinations, echocardiography, and genetic testing.
Key Findings:
  • Echocardiographic abnormalities were observed in 4 out of 55 (7%) athletes.
  • 5 out of 55 (9%) displayed echocardiographic findings resembling physiological adaptation.
  • Clinically relevant dysmorphic features were identified in 26 out of 55 (47%).
  • Mild dysmorphia was present in 21 out of 55 (38%) participants.
  • No endocrine dysfunctions were detected.
  • 1 proband (1.8%) was diagnosed with Marfan syndrome due to a pathogenic variant in the FBN1 gene.
Interpretation:

Echocardiographic abnormalities and monogenic causes of tall stature were found in a small proportion of athletes, suggesting targeted evaluation may be beneficial.

Limitations:
  • The study sample size was limited to 55 participants.
  • The findings may not be generalizable to all young athletes.
Conclusion:

Targeted evaluation, including echocardiography, anthropometry, and genetic testing, should be considered in selected individuals.

Original Source(s)

Related Content